Paper36979503
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.
Kuang Z and 5 others. Biomolecules, 2023. Cited by 27 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity. Papers, record 36979503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979503
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Cardiotoxicity | |
| Doxorubicin | |
| Biomarkers | |
| Myocytes, Cardiac |
Source PubMed
References220
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,873,641 | MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35873641 | PubMed |
| 2 | 27,284,328 | Paeoniflorin inhibits doxorubicin-induced cardiomyocyte apoptosis by downregulating microRNA-1 expression. | Exp Ther Med | 2016 | https://conductscience.org/library/papers/27284328 | PubMed |
| 3 | 30,338,246 | Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro. | J Biol Res (Thessalon) | 2018 | https://conductscience.org/library/papers/30338246 | PubMed |
| 4 | 33,638,775 | MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway. | Cardiovasc Toxicol | 2021 | https://conductscience.org/library/papers/33638775 | PubMed |
| 5 | 27,990,619 | Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and Atria. | Cardiovasc Toxicol | 2017 | https://conductscience.org/library/papers/27990619 | PubMed |
| 6 | 22,716,973 | The burden of disease and the changing task of medicine. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22716973 | PubMed |
| 7 | 34,786,071 | miR-21-5p inhibits inflammation injuries in LPS-treated H9c2 cells by regulating PDCD4. | Am J Transl Res | 2021 | https://conductscience.org/library/papers/34786071 | PubMed |
| 8 | 25,448,438 | Early biomarkers of doxorubicin-induced heart injury in a mouse model. | Toxicol Appl Pharmacol | 2014 | https://conductscience.org/library/papers/25448438 | PubMed |
| 9 | 22,859,947 | Perturbation of microRNAs in rat heart during chronic doxorubicin treatment. | PLoS One | 2012 | https://conductscience.org/library/papers/22859947 | PubMed |
| 10 | 32,215,566 | Non-coding RNA therapeutics for cardiac regeneration. | Cardiovasc Res | 2021 | https://conductscience.org/library/papers/32215566 | PubMed |
| 11 | 32,186,283 | The Effects of Inhibition of MicroRNA-375 in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity. | Med Sci Monit | 2020 | https://conductscience.org/library/papers/32186283 | PubMed |
| 12 | 31,159,424 | Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31159424 | PubMed |
| 13 | 30,025,410 | MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/30025410 | PubMed |
| 14 | 34,166,713 | An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity. | Life Sci | 2021 | https://conductscience.org/library/papers/34166713 | PubMed |
| 15 | 34,592,896 | Selectivity of Exportin 5 binding to human precursor microRNAs. | RNA Biol | 2021 | https://conductscience.org/library/papers/34592896 | PubMed |
| 16 | 31,149,048 | Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction. | Theranostics | 2019 | https://conductscience.org/library/papers/31149048 | PubMed |
| 17 | 22,052,916 | Mitochondrial fusion is essential for organelle function and cardiac homeostasis. | Circ Res | 2011 | https://conductscience.org/library/papers/22052916 | PubMed |
| 18 | 32,638,021 | Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. | Cardiovasc Res | 2020 | https://conductscience.org/library/papers/32638021 | PubMed |
| 19 | 36,416,353 | MicroRNAs target the PI3K/Akt/p53 and the Sirt1/Nrf2 signaling pathways in doxorubicin-induced cardiotoxicity. | J Biochem Mol Toxicol | 2023 | https://conductscience.org/library/papers/36416353 | PubMed |
| 20 | 30,460,422 | MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity. | Arch Toxicol | 2019 | https://conductscience.org/library/papers/30460422 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,941,994 | Polyphenols and Flavonoids in microRNA-Regulated Pathways of Doxorubicin-Induced Cardiotoxicity: Mechanistic Evidence, Biomarker Potential and Translational Gaps. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941994 | PubMed |
| 42,752,650 | Doxorubicin-induced hepatotoxicity: a multifaceted pathogenesis from mitochondrial collapse to immune remodeling and epigenetic memory. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42752650 | PubMed |
| 41,929,414 | Neoadjuvant chemotherapy and perioperative cardiotoxicity. | J Anesth Transl Med | 2024 | https://conductscience.org/library/papers/41929414 | PubMed |
| 41,469,745 | Cardiomyocyte overexpression of microRNA-210 mitigates apoptotic cell death induced by doxorubicin. | Cardiooncology | 2025 | https://conductscience.org/library/papers/41469745 | PubMed |
| 41,225,749 | MiR-145-5p Attenuates Doxorubicin-Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/41225749 | PubMed |
| 41,021,886 | FOXO1-NMNAT3 axis dysregulation promotes doxorubicin cardiotoxicity: NAD+ replenishment as a redox-targeted antioxidant therapy. | Redox Rep | 2025 | https://conductscience.org/library/papers/41021886 | PubMed |
| 40,918,193 | MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40918193 | PubMed |
| 40,917,031 | MiRNA Regulations in Cardiotoxicity Induced by Oncologic Therapies and Possible Immune Response. | Curr Med Chem | 2026 | https://conductscience.org/library/papers/40917031 | PubMed |
| 40,677,631 | Roles of Non-Coding RNA in Anthracycline Cardiotoxicity: A Narrative Review. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40677631 | PubMed |
| 40,560,279 | Small Interfering RNA (siRNA) for Cardiorenal Disease: Mechanistic Insights from Preclinical and Clinical Studies. | J Cardiovasc Transl Res | 2025 | https://conductscience.org/library/papers/40560279 | PubMed |
| 39,865,410 | Edaravone is a Therapeutic Candidate for Doxorubicin-Induced Cardiomyopathy by Activating the Nrf2 Pathway. | Pharmacol Res Perspect | 2025 | https://conductscience.org/library/papers/39865410 | PubMed |
| 39,854,052 | Indole-3-Lactic Acid Inhibits Doxorubicin-Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/39854052 | PubMed |
| 39,769,102 | The Role of MicroRNAs in the Pathogenesis of Doxorubicin-Induced Vascular Remodeling. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769102 | PubMed |
| 39,595,980 | Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39595980 | PubMed |
| 39,018,487 | Circ-0006332 stimulates cardiomyocyte pyroptosis via the miR-143/TLR2 axis to promote doxorubicin-induced cardiac damage. | Epigenetics | 2024 | https://conductscience.org/library/papers/39018487 | PubMed |
| 38,391,053 | Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer. | Int J Oncol | 2024 | https://conductscience.org/library/papers/38391053 | PubMed |
| 38,235,109 | Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38235109 | PubMed |
| 37,142,272 | Exosomal miR-663b from "M1" macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through inhibiting the AMPK/Sirt1 axis. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37142272 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979503
GET https://conductscience.org/api/papers/v1/36979503/references?page=2